Article
Glibenclamide modulates microglial function and attenuates Aβ deposition in 5XFAD mice.
European journal of pharmacology - 5 Oct 2020
Ju Yeon-Joo, Kim Namkwon, Gee Min Sung, Jeon Seung Ho, Lee Danbi, Do Jimin, Ryu Jong-Sik, Lee Jong Kil
Abstract excerpt
Severe neuroinflammation is known as a main pathology of neurodegenerative disorders such as Alzheimer's disease (AD) and Parkinson's disease (PD). In these diseases, excessive microglial activation is one of the main causes of inflammation in the central nervous system. Therefore, inhibition of activated microglia may be suggested as a treatment for neuroinflammatory diseases. Glibenclamide, known as a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
